RIZZOTTO, Lara
 Distribuzione geografica
Continente #
NA - Nord America 3.775
AS - Asia 1.970
EU - Europa 1.091
SA - Sud America 246
AF - Africa 41
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.128
Nazione #
US - Stati Uniti d'America 3.696
SG - Singapore 780
CN - Cina 501
DE - Germania 267
VN - Vietnam 249
BR - Brasile 193
UA - Ucraina 152
IT - Italia 140
HK - Hong Kong 130
GB - Regno Unito 126
TR - Turchia 120
FI - Finlandia 77
FR - Francia 76
RU - Federazione Russa 59
SE - Svezia 59
JP - Giappone 47
CA - Canada 44
IN - India 42
MX - Messico 30
BD - Bangladesh 22
ES - Italia 22
BE - Belgio 20
PL - Polonia 20
CZ - Repubblica Ceca 19
ID - Indonesia 18
ZA - Sudafrica 16
NL - Olanda 14
AR - Argentina 13
PK - Pakistan 12
LT - Lituania 11
CO - Colombia 10
CL - Cile 9
VE - Venezuela 9
IQ - Iraq 8
MA - Marocco 8
RO - Romania 7
MY - Malesia 6
AT - Austria 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
BO - Bolivia 4
EG - Egitto 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
JO - Giordania 3
PH - Filippine 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
DZ - Algeria 2
IE - Irlanda 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LY - Libia 2
MT - Malta 2
NG - Nigeria 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TZ - Tanzania 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 7.128
Città #
Singapore 512
Ashburn 455
Woodbridge 358
Chandler 253
Fairfield 252
San Jose 239
Beijing 206
Santa Clara 177
Jacksonville 170
Houston 151
Ann Arbor 150
Hong Kong 126
Seattle 112
Wilmington 100
Cambridge 97
Dallas 92
New York 86
Ho Chi Minh City 82
Los Angeles 66
Izmir 64
Munich 61
Hanoi 58
Ferrara 49
Tokyo 45
Nanjing 42
Princeton 38
Shanghai 36
Lauterbourg 34
Boardman 33
Milan 31
São Paulo 27
Helsinki 23
San Diego 23
Bremen 22
London 22
Buffalo 20
Mexico City 20
Orem 20
Brussels 19
Turku 19
Shenyang 18
Warsaw 18
Dearborn 17
Montreal 17
Frankfurt am Main 16
Nanchang 16
Addison 15
Brno 15
Denver 15
The Dalles 14
Tianjin 14
Brooklyn 13
Changsha 13
Johannesburg 13
Stockholm 13
Da Nang 12
San Francisco 12
Chennai 11
Manchester 11
Amsterdam 10
Guangzhou 10
Toronto 10
Jiaxing 9
Jinan 9
Moscow 9
Mumbai 9
Zhengzhou 9
Falkenstein 8
Haiphong 8
Jakarta 8
Poplar 8
Auburn Hills 7
Biên Hòa 7
Chicago 7
Columbus 7
Dortmund 7
Hefei 7
Mountain View 7
Paris 7
Phoenix 7
Reynoldsburg 7
Rio de Janeiro 7
Atlanta 6
Council Bluffs 6
Norwalk 6
Orange 6
Bexley 5
Bologna 5
Boston 5
Bến Tre 5
Caracas 5
Falls Church 5
Guarulhos 5
Ninh Bình 5
Washington 5
Augusta 4
Calgary 4
Can Tho 4
Hải Dương 4
Lahore 4
Totale 4.936
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 284
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 257
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 248
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 244
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 237
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 236
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 232
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 225
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 224
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 219
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 217
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 214
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 206
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 204
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 195
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 192
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 186
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 185
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 182
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 181
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 174
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 173
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 172
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 170
Rescue of coagulation factor VII function by the U1+5A snRNA 168
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 162
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 161
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 150
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 147
Non-conventional therapeutic strategies for inherited disorders of hemostasis 144
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 131
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 129
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 126
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector 124
Erratum to: Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance (Cancer (2010) 116, (1926-37)) 106
Naturally occurring truncated proteins: decreased protein secretion and increased activity result in asymptomatic coagulation factor deficiency 105
“Compensatory” aberrant splicing supports residual expression levels in severe coagulation factor VII deficiency 104
null 94
null 82
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 77
null 64
null 42
Totale 7.173
Categoria #
all - tutte 28.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021169 0 0 0 0 0 0 0 0 0 53 81 35
2021/2022442 38 55 27 10 29 18 16 21 9 34 50 135
2022/2023524 49 52 8 80 96 68 28 44 66 2 22 9
2023/2024233 25 26 9 3 12 50 9 12 8 6 3 70
2024/2025986 14 24 73 45 137 107 9 22 162 91 142 160
2025/20262.800 333 113 242 380 468 223 394 164 243 240 0 0
Totale 7.173